Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5990)
All Articles published online
|
Sep 21, 2014 (publication date) through Jan 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou YM, Zhang XF, Wu LP, Sui CJ, Yang JM. Risk factors for combined hepatocellular-cholangiocarcinoma: A hospital-based case-control study. World J Gastroenterol 2014; 20(35): 12615-12620 [PMID: 25253966 DOI: 10.3748/wjg.v20.i35.12615] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i35/12615.htm |
| Number | Citing Articles |
| 1 |
Cheng Lou, Tong Bai, Le-Wei Bi, Ying-Tang Gao, Zhi Du. Negative impact of hepatitis B surface seroclearance on prognosis of hepatitis B-related primary liver cancer. World Journal of Clinical Cases 2018; 6(8): 192-199 doi: 10.12998/wjcc.v6.i8.192
|
| 2 |
翰林 王. A Case Analysis and Literature Review of Combined Hepatocellular-Cholangiocarcinoma after Operation. Advances in Clinical Medicine 2023; 13(01): 824 doi: 10.12677/ACM.2023.131120
|
| 3 |
Shweta Gera, Mark Ettel, Gabriel Acosta-Gonzalez, Ruliang Xu. Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma. World Journal of Hepatology 2017; 9(6): 300-309 doi: 10.4254/wjh.v9.i6.300
|
| 4 |
Hao Zhang, Biqing Zhu, He Zhang, Jianxin Liang, Wenting Zeng. HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/3417976
|
| 5 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 481 doi: 10.1007/978-3-319-26956-6_26
|
| 6 |
Dimitrios Schizas, Aikaterini Mastoraki, Eleni Routsi, Michail Papapanou, Dimitrios Tsapralis, Pantelis Vassiliu, Konstantinos Toutouzas, Evangelos Felekouras. Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management. Hepatobiliary & Pancreatic Diseases International 2020; 19(6): 515 doi: 10.1016/j.hbpd.2020.07.004
|
| 7 |
Ana Alicia Tejera-Hernández, Mercedes Elisa Cabrera-García, María Soledad Martínez-Martin, Gabriel García-Plaza, Francisco Javier Larrea-Olea, Juan Ramón Hernández-Hernández. Hepatocolangiocarcinoma en paciente joven con tumoración hepática gigante. Cirugía y Cirujanos 2017; 85(3): 250 doi: 10.1016/j.circir.2015.10.015
|
| 8 |
Yan-Ming Zhou, Cheng-Jun Sui, Xiao-Feng Zhang, Bin Li, Jia-Mei Yang. Influence of cirrhosis on long-term prognosis after surgery in patients with combined hepatocellular-cholangiocarcinoma. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0584-y
|
| 9 |
Matteo Renzulli, Daryl Ramai, Jameel Singh, Samridhi Sinha, Nicolò Brandi, Anna Maria Ierardi, Elisa Albertini, Rodolfo Sacco, Antonio Facciorusso, Rita Golfieri. Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma. Cancers 2021; 13(13): 3336 doi: 10.3390/cancers13133336
|
| 10 |
Carmen Cutolo, Federica Dell’Aversana, Roberta Fusco, Giulia Grazzini, Giuditta Chiti, Igino Simonetti, Federico Bruno, Pierpaolo Palumbo, Luca Pierpaoli, Tommaso Valeri, Francesco Izzo, Andrea Giovagnoni, Roberto Grassi, Vittorio Miele, Antonio Barile, Vincenza Granata. Combined Hepatocellular-Cholangiocarcinoma: What the Multidisciplinary Team Should Know. Diagnostics 2022; 12(4): 890 doi: 10.3390/diagnostics12040890
|
| 11 |
Johannes Eschrich, Zuzanna Kobus, Dominik Geisel, Sebastian Halskov, Florian Roßner, Christoph Roderburg, Raphael Mohr, Frank Tacke. The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma—State of the Art and Future Perspectives. Cancers 2023; 15(1): 301 doi: 10.3390/cancers15010301
|
| 12 |
Agnieszka Anysz-Grodzicka, Joanna Podgorska, Andrzej Cieszanowski. State-of-the-art MR Imaging of Uncommon Hepatocellular Tumours: Fibrolamellar Hepatocellular Carcinoma and Combined Hepatocellularcholangiocarcinoma. Current Medical Imaging Formerly Current Medical Imaging Reviews 2019; 15(3): 269 doi: 10.2174/1573405614666180927113622
|
| 13 |
Fan Zhang, Chong-De Lu, Xiu-Ping Zhang, Zhen-Hua Chen, Cheng-Qian Zhong, Yi-Ren Hu, Xu-Biao Wei, Bin Zhou, Kang Wang, Zong-Tao Chai, Meng-Chao Wu, Wan Y. Lau, Shu-Qun Cheng. The impact of portal vein tumor thrombus on long-term survival after liver resection for primary hepatic malignancy. HPB 2020; 22(7): 1025 doi: 10.1016/j.hpb.2019.10.2439
|
| 14 |
Liangtao Ye, Julia S. Schneider, Najib Ben Khaled, Peter Schirmacher, Carolin Seifert, Lea Frey, Yulong He, Andreas Geier, Enrico N. De Toni, Changhua Zhang, Florian P. Reiter. Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management. Liver Cancer 2024; 13(1): 6 doi: 10.1159/000530700
|
| 15 |
Vincenza Granata, Roberta Fusco, Sergio Venanzio Setola, Fabio Sandomenico, Maria Luisa Barretta, Andrea Belli, Raffaele Palaia, Fabiana Tatangelo, Roberta Grassi, Francesco Izzo, Antonella Petrillo. Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinoma. Radiology and Oncology 2020; 54(2): 149 doi: 10.2478/raon-2020-0029
|
| 16 |
Elia Gigante, Valérie Paradis, Maxime Ronot, François Cauchy, Olivier Soubrane, Nathalie Ganne-Carrié, Jean-Charles Nault. New insights into the pathophysiology and clinical care of rare primary liver cancers. JHEP Reports 2021; 3(1): 100174 doi: 10.1016/j.jhepr.2020.100174
|
| 17 |
Tomoki Sempokuya, Eric A Wien, Robert J Pattison, Jihyun Ma, Linda L Wong. Factors associated with 5-year survival of combined hepatocellular and cholangiocarcinoma. World Journal of Hepatology 2020; 12(11): 1020-1030 doi: 10.4254/wjh.v12.i11.1020
|
| 18 |
Kathryn Fowler, Nael E. Saad, Elizabeth Brunt, M. B. Majella Doyle, Manik Amin, Neeta Vachharajani, Benjamin Tan, William C. Chapman. Biphenotypic Primary Liver Carcinomas: Assessing Outcomes of Hepatic Directed Therapy. Annals of Surgical Oncology 2015; 22(13): 4130 doi: 10.1245/s10434-015-4774-y
|
| 19 |
Adrian Kuzmanović, Cheng Lin, Matthias Bartneck. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2023; 3: 283 doi: 10.1007/16833_2023_129
|
| 20 |
Yu-Ting Shen, Wen-Wen Yue, Hui-Xiong Xu. Non-invasive imaging in the diagnosis of combined hepatocellular carcinoma and cholangiocarcinoma. Abdominal Radiology 2023; 48(6): 2019 doi: 10.1007/s00261-023-03879-0
|
| 21 |
Megha Nayyar, David K. Imagawa, Temel Tirkes, Aram N. Demirjian, Roozbeh Houshyar, Kumar Sandrasegaran, Chaitali S. Nangia, Tara Seery, P Bhargava, Joon II Choi, Chandana Lall. Composite liver tumors: A radiologic-pathologic correlation. Clinical and Molecular Hepatology 2014; 20(4): 406 doi: 10.3350/cmh.2014.20.4.406
|
| 22 |
Linghao Zhao, Yuyouye Wang, Tao Tian, Xinjie Rao, Wei Dong, Jinmin Zhang, Yuan Yang, Qifei Tao, Fang Peng, Chenhang Shen, Songbo Wang, Hui Liu, Xi Zeng, Weiping Zhou. Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma. Hepatology International 2022; 16(6): 1339 doi: 10.1007/s12072-022-10419-3
|
| 23 |
|
| 24 |
An-Qiang Wang, Yong-Chang Zheng, Juan Du, Cheng-Pei Zhu, Han-Chun Huang, Shan-Shan Wang, Liang-Cai Wu, Xue-Shuai Wan, Hao-Hai Zhang, Ruo-Yu Miao, Xin-Ting Sang, Hai-Tao Zhao. Combined hepatocellular cholangiocarcinoma: Controversies to be addressed. World Journal of Gastroenterology 2016; 22(18): 4459-4465 doi: 10.3748/wjg.v22.i18.4459
|
| 25 |
Min Dai, Yue-Wu Yang, Wen-Hai Guo, Feng-Lin Wang, Ge-Min Xiao, Yang-Mei Li, Hong-Zhi Yang, Kieran Cooley. Addition and Subtraction Theory of TCM Using Xiao‐Chaihu‐Decoction and Naturopathy in Predicting Survival Outcomes of Primary Liver Cancer Patients: A Prospective Cohort Study. Evidence-Based Complementary and Alternative Medicine 2016; 2016(1) doi: 10.1155/2016/4723530
|
| 26 |
Tsuyoshi Hamada, Yousuke Nakai. Management of Pancreatic Cancer and Cholangiocarcinoma. 2021; : 3 doi: 10.1007/978-981-16-2870-2_1
|
| 27 |
Heinz Zoller, Herbert Tilg. Nonalcoholic fatty liver disease and hepatocellular carcinoma. Metabolism 2016; 65(8): 1151 doi: 10.1016/j.metabol.2016.01.010
|
| 28 |
Hao Zhang, Xiaojiong Yu, Jian Xu, Juan Li, Yao Zhou. Combined hepatocellular-cholangiocarcinoma. Medicine 2019; 98(38): e17102 doi: 10.1097/MD.0000000000017102
|
| 29 |
Ana Alicia Tejera-Hernández, Mercedes Elisa Cabrera-García, María Soledad Martínez-Martin, Gabriel García-Plaza, Francisco Javier Larrea-Olea, Juan Ramón Hernández-Hernández. Hepatocholangiocarcinoma in young patient with a giant liver tumour. Cirugía y Cirujanos (English Edition) 2017; 85(3): 250 doi: 10.1016/j.circen.2017.05.001
|
| 30 |
Rick Y. Lin, Doga Kahramangil, Muhammet Ozer, Thomas J. George, Ibrahim Nassour, Steven J. Hughes, Ali Zarrinpar, Ilyas Sahin. Patient Outcomes in Resected Combined Hepatocellular Cholangiocarcinoma (cHCC-ICC) and Intrahepatic Cholangiocarcinoma: A Single Center Study. Cancers 2024; 16(22): 3878 doi: 10.3390/cancers16223878
|
| 31 |
Nittaya Chamadol, Narong Khuntikeo, Bandit Thinkhamrop, Kavin Thinkhamrop, Apiporn T Suwannatrai, Matthew Kelly, Supannee Promthet. Association between periductal fibrosis and bile duct dilatation among a population at high risk of cholangiocarcinoma: a cross-sectional study of cholangiocarcinoma screening in Northeast Thailand. BMJ Open 2019; 9(3): e023217 doi: 10.1136/bmjopen-2018-023217
|
| 32 |
Tomoyuki Satake, Taro Shibuki, Kazuo Watanabe, Mitsuhito Sasaki, Hiroshi Imaoka, Shuichi Mitsunaga, Motohiro Kojima, Masafumi Ikeda. Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1234113
|
| 33 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_26-1
|
| 34 |
Naoto Saito, Takeshi Hatanaka, Sachi Nakano, Yoichi Hazama, Sachiko Yoshida, Yoko Hachisu, Yoshiki Tanaka, Teruo Yoshinaga, Kenji Kashiwabara, Norio Kubo, Yasuo Hosouchi, Hiroki Tojima, Satoru Kakizaki, Toshio Uraoka. A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab. Clinical Case Reports 2022; 10(7) doi: 10.1002/ccr3.6129
|